Coloplast A/S (LON:0QBO)

Coloplast Statistics

Total Valuation

Coloplast has a market cap or net worth of GBP 15.81 billion. The enterprise value is 18.54 billion.

Market Cap	15.81B
Enterprise Value	18.54B

Important Dates

The next estimated earnings date is Tuesday, August 19, 2025.

Earnings Date	Aug 19, 2025
Ex-Dividend Date	May 8, 2025

Share Statistics

Current Share Class	207.17M
Shares Outstanding	n/a
Shares Change (YoY)	+1.60%
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	142.64M

Valuation Ratios

The trailing PE ratio is 31.02 and the forward PE ratio is 25.61.

PE Ratio	31.02
Forward PE	25.61
PS Ratio	5.07
PB Ratio	8.32
P/TBV Ratio	n/a
P/FCF Ratio	28.03
P/OCF Ratio	22.42
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.31, with an EV/FCF ratio of 32.88.

EV / Earnings	36.38
EV / Sales	5.74
EV / EBITDA	18.31
EV / EBIT	21.28
EV / FCF	32.88

Financial Position

The company has a current ratio of 0.95, with a Debt / Equity ratio of 1.43.

Current Ratio	0.95
Quick Ratio	0.57
Debt / Equity	1.43
Debt / EBITDA	2.78
Debt / FCF	4.82
Interest Coverage	9.07

Financial Efficiency

Return on equity (ROE) is 27.42% and return on invested capital (ROIC) is 11.45%.

Return on Equity (ROE)	27.42%
Return on Assets (ROA)	9.64%
Return on Invested Capital (ROIC)	11.45%
Return on Capital Employed (ROCE)	19.65%
Revenue Per Employee	186,185
Profits Per Employee	30,439
Employee Count	16,639
Asset Turnover	0.57
Inventory Turnover	2.45

Taxes

In the past 12 months, Coloplast has paid 218.68 million in taxes.

Income Tax	218.68M
Effective Tax Rate	30.03%

Stock Price Statistics

The stock price has decreased by -30.55% in the last 52 weeks. The beta is 0.55, so Coloplast's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	-30.55%
50-Day Moving Average	628.20
200-Day Moving Average	766.76
Relative Strength Index (RSI)	36.42
Average Volume (20 Days)	54,469

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Coloplast had revenue of GBP 3.12 billion and earned 509.58 million in profits. Earnings per share was 2.26.

Revenue	3.12B
Gross Profit	2.10B
Operating Income	841.30M
Pretax Income	728.26M
Net Income	509.58M
EBITDA	945.26M
EBIT	841.30M
Earnings Per Share (EPS)	2.26

Balance Sheet

The company has 81.75 million in cash and 2.72 billion in debt, giving a net cash position of -2.64 billion.

Cash & Cash Equivalents	81.75M
Total Debt	2.72B
Net Cash	-2.64B
Net Cash Per Share	n/a
Equity (Book Value)	1.90B
Book Value Per Share	8.44
Working Capital	-56.07M

Cash Flow

In the last 12 months, operating cash flow was 705.05 million and capital expenditures -141.08 million, giving a free cash flow of 563.97 million.

Operating Cash Flow	705.05M
Capital Expenditures	-141.08M
Free Cash Flow	563.97M
FCF Per Share	n/a

Margins

Gross margin is 67.52%, with operating and profit margins of 26.99% and 16.35%.

Gross Margin	67.52%
Operating Margin	26.99%
Pretax Margin	23.36%
Profit Margin	16.35%
EBITDA Margin	30.33%
EBIT Margin	26.99%
FCF Margin	18.09%

Dividends & Yields

This stock pays an annual dividend of 2.46, which amounts to a dividend yield of 0.40%.

Dividend Per Share	2.46
Dividend Yield	0.40%
Dividend Growth (YoY)	1.72%
Years of Dividend Growth	9
Payout Ratio	109.07%
Buyback Yield	-1.60%
Shareholder Yield	-1.19%
Earnings Yield	3.22%
FCF Yield	3.57%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on December 19, 2012. It was a forward split with a ratio of 5.

Last Split Date	Dec 19, 2012
Split Type	Forward
Split Ratio	5

Scores

Coloplast has an Altman Z-Score of 5.13 and a Piotroski F-Score of 6.

Altman Z-Score	5.13
Piotroski F-Score	6